nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbachol—PLA2G4A—Epirubicin—prostate cancer	0.472	1	CbGbCtD
Carbachol—CHRM3—ureter—prostate cancer	0.0305	0.369	CbGeAlD
Carbachol—CHRNA2—prostate gland—prostate cancer	0.00731	0.0887	CbGeAlD
Carbachol—PLA2G4A—prostate gland—prostate cancer	0.00592	0.0718	CbGeAlD
Carbachol—PLA2G4A—seminal vesicle—prostate cancer	0.00501	0.0607	CbGeAlD
Carbachol—CHRM2—prostate gland—prostate cancer	0.00436	0.0529	CbGeAlD
Carbachol—PLA2G4A—renal system—prostate cancer	0.00403	0.0489	CbGeAlD
Carbachol—CHRM1—prostate gland—prostate cancer	0.00397	0.0481	CbGeAlD
Carbachol—PLA2G4A—urethra—prostate cancer	0.00396	0.048	CbGeAlD
Carbachol—CHRM3—prostate gland—prostate cancer	0.00355	0.0431	CbGeAlD
Carbachol—PLA2G4A—bone marrow—prostate cancer	0.00305	0.037	CbGeAlD
Carbachol—PLA2G4A—testis—prostate cancer	0.00261	0.0316	CbGeAlD
Carbachol—Choline—PDE4D—prostate cancer	0.00261	0.308	CrCbGaD
Carbachol—CHRM3—renal system—prostate cancer	0.00242	0.0294	CbGeAlD
Carbachol—CHRM3—urethra—prostate cancer	0.00238	0.0288	CbGeAlD
Carbachol—Choline—SLC22A3—prostate cancer	0.00223	0.264	CrCbGaD
Carbachol—Choline—ACHE—prostate cancer	0.00202	0.239	CrCbGaD
Carbachol—PLA2G4A—Estradiol—Estradiol valerate/Dienogest—prostate cancer	0.00201	0.262	CbGdCrCtD
Carbachol—PLA2G4A—lymph node—prostate cancer	0.00189	0.0229	CbGeAlD
Carbachol—PLA2G4A—Estradiol—Estramustine—prostate cancer	0.00171	0.223	CbGdCrCtD
Carbachol—Choline—SLC22A1—prostate cancer	0.0016	0.189	CrCbGaD
Carbachol—CHRM3—testis—prostate cancer	0.00157	0.019	CbGeAlD
Carbachol—PLA2G4A—Estradiol—Estrone—prostate cancer	0.00136	0.177	CbGdCrCtD
Carbachol—PLA2G4A—Estradiol—Conjugated Estrogens—prostate cancer	0.0012	0.156	CbGdCrCtD
Carbachol—PLA2G4A—Estradiol—Ethinyl Estradiol—prostate cancer	0.001	0.131	CbGdCrCtD
Carbachol—Muscle spasms—Goserelin—prostate cancer	0.000641	0.00232	CcSEcCtD
Carbachol—Nausea—Flutamide—prostate cancer	0.000641	0.00232	CcSEcCtD
Carbachol—Dizziness—Degarelix—prostate cancer	0.00064	0.00232	CcSEcCtD
Carbachol—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000638	0.00231	CcSEcCtD
Carbachol—Phlebitis—Capecitabine—prostate cancer	0.000635	0.0023	CcSEcCtD
Carbachol—Muscle spasms—Conjugated Estrogens—prostate cancer	0.000635	0.0023	CcSEcCtD
Carbachol—Diarrhoea—Cabazitaxel—prostate cancer	0.000624	0.00226	CcSEcCtD
Carbachol—Necrosis—Doxorubicin—prostate cancer	0.000619	0.00224	CcSEcCtD
Carbachol—Abdominal pain—Bicalutamide—prostate cancer	0.000618	0.00224	CcSEcCtD
Carbachol—Body temperature increased—Bicalutamide—prostate cancer	0.000618	0.00224	CcSEcCtD
Carbachol—Vomiting—Degarelix—prostate cancer	0.000615	0.00223	CcSEcCtD
Carbachol—Abscess—Doxorubicin—prostate cancer	0.000614	0.00223	CcSEcCtD
Carbachol—Cramp muscle—Etoposide—prostate cancer	0.000613	0.00222	CcSEcCtD
Carbachol—Rash—Degarelix—prostate cancer	0.00061	0.00221	CcSEcCtD
Carbachol—Dermatitis—Degarelix—prostate cancer	0.00061	0.00221	CcSEcCtD
Carbachol—Headache—Degarelix—prostate cancer	0.000606	0.0022	CcSEcCtD
Carbachol—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000605	0.00219	CcSEcCtD
Carbachol—Sweating—Mitoxantrone—prostate cancer	0.000604	0.00219	CcSEcCtD
Carbachol—Dizziness—Cabazitaxel—prostate cancer	0.000603	0.00219	CcSEcCtD
Carbachol—Extravasation—Epirubicin—prostate cancer	0.000602	0.00218	CcSEcCtD
Carbachol—Stinging—Doxorubicin—prostate cancer	0.0006	0.00217	CcSEcCtD
Carbachol—Syncope—Conjugated Estrogens—prostate cancer	0.000592	0.00215	CcSEcCtD
Carbachol—Loss of consciousness—Conjugated Estrogens—prostate cancer	0.00058	0.0021	CcSEcCtD
Carbachol—Vomiting—Cabazitaxel—prostate cancer	0.00058	0.0021	CcSEcCtD
Carbachol—Nausea—Degarelix—prostate cancer	0.000575	0.00208	CcSEcCtD
Carbachol—Sweating increased—Etoposide—prostate cancer	0.000573	0.00208	CcSEcCtD
Carbachol—Headache—Cabazitaxel—prostate cancer	0.000571	0.00207	CcSEcCtD
Carbachol—Hyponatraemia—Docetaxel—prostate cancer	0.000568	0.00206	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Docetaxel—prostate cancer	0.000565	0.00205	CcSEcCtD
Carbachol—Flushing—Estradiol—prostate cancer	0.000564	0.00204	CcSEcCtD
Carbachol—Extravasation—Doxorubicin—prostate cancer	0.000557	0.00202	CcSEcCtD
Carbachol—Ulcer—Epirubicin—prostate cancer	0.000555	0.00201	CcSEcCtD
Carbachol—Hyponatraemia—Capecitabine—prostate cancer	0.00055	0.00199	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Capecitabine—prostate cancer	0.000547	0.00198	CcSEcCtD
Carbachol—Nausea—Cabazitaxel—prostate cancer	0.000542	0.00196	CcSEcCtD
Carbachol—Infection—Goserelin—prostate cancer	0.000541	0.00196	CcSEcCtD
Carbachol—Infection—Conjugated Estrogens—prostate cancer	0.000535	0.00194	CcSEcCtD
Carbachol—Shock—Goserelin—prostate cancer	0.000535	0.00194	CcSEcCtD
Carbachol—Diarrhoea—Bicalutamide—prostate cancer	0.000535	0.00194	CcSEcCtD
Carbachol—Shock—Conjugated Estrogens—prostate cancer	0.00053	0.00192	CcSEcCtD
Carbachol—Hyperhidrosis—Goserelin—prostate cancer	0.000526	0.00191	CcSEcCtD
Carbachol—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.000523	0.00189	CcSEcCtD
Carbachol—Abdominal pain—Ethinyl Estradiol—prostate cancer	0.000523	0.00189	CcSEcCtD
Carbachol—Hyperhidrosis—Conjugated Estrogens—prostate cancer	0.000521	0.00189	CcSEcCtD
Carbachol—Flatulence—Estradiol—prostate cancer	0.000521	0.00189	CcSEcCtD
Carbachol—Dizziness—Bicalutamide—prostate cancer	0.000517	0.00188	CcSEcCtD
Carbachol—Hyperkalaemia—Epirubicin—prostate cancer	0.000516	0.00187	CcSEcCtD
Carbachol—Ulcer—Doxorubicin—prostate cancer	0.000514	0.00186	CcSEcCtD
Carbachol—Salivary hypersecretion—Epirubicin—prostate cancer	0.00051	0.00185	CcSEcCtD
Carbachol—Cramp muscle—Docetaxel—prostate cancer	0.000509	0.00185	CcSEcCtD
Carbachol—Hypotension—Goserelin—prostate cancer	0.000508	0.00184	CcSEcCtD
Carbachol—Muscle spasms—Estradiol—prostate cancer	0.000508	0.00184	CcSEcCtD
Carbachol—Arrhythmia—Mitoxantrone—prostate cancer	0.000505	0.00183	CcSEcCtD
Carbachol—Hypotension—Conjugated Estrogens—prostate cancer	0.000504	0.00183	CcSEcCtD
Carbachol—Vomiting—Bicalutamide—prostate cancer	0.000497	0.0018	CcSEcCtD
Carbachol—Rash—Bicalutamide—prostate cancer	0.000493	0.00179	CcSEcCtD
Carbachol—Dermatitis—Bicalutamide—prostate cancer	0.000493	0.00179	CcSEcCtD
Carbachol—Headache—Bicalutamide—prostate cancer	0.00049	0.00178	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Prednisone—prostate cancer	0.000488	0.00177	CcSEcCtD
Carbachol—Dyspepsia—Goserelin—prostate cancer	0.000479	0.00174	CcSEcCtD
Carbachol—Hyperkalaemia—Doxorubicin—prostate cancer	0.000478	0.00173	CcSEcCtD
Carbachol—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000474	0.00172	CcSEcCtD
Carbachol—Syncope—Estradiol—prostate cancer	0.000474	0.00172	CcSEcCtD
Carbachol—Asthma—Capecitabine—prostate cancer	0.000473	0.00171	CcSEcCtD
Carbachol—Salivary hypersecretion—Doxorubicin—prostate cancer	0.000472	0.00171	CcSEcCtD
Carbachol—Pain—Goserelin—prostate cancer	0.000465	0.00169	CcSEcCtD
Carbachol—Nausea—Bicalutamide—prostate cancer	0.000465	0.00168	CcSEcCtD
Carbachol—Loss of consciousness—Estradiol—prostate cancer	0.000465	0.00168	CcSEcCtD
Carbachol—Pain—Conjugated Estrogens—prostate cancer	0.000461	0.00167	CcSEcCtD
Carbachol—Sweating increased—Capecitabine—prostate cancer	0.000461	0.00167	CcSEcCtD
Carbachol—Abdominal discomfort—Capecitabine—prostate cancer	0.000454	0.00164	CcSEcCtD
Carbachol—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000452	0.00164	CcSEcCtD
Carbachol—Phlebitis—Epirubicin—prostate cancer	0.000443	0.0016	CcSEcCtD
Carbachol—Dizziness—Ethinyl Estradiol—prostate cancer	0.000437	0.00159	CcSEcCtD
Carbachol—Flushing—Etoposide—prostate cancer	0.000437	0.00158	CcSEcCtD
Carbachol—Body temperature increased—Goserelin—prostate cancer	0.00043	0.00156	CcSEcCtD
Carbachol—Abdominal pain—Goserelin—prostate cancer	0.00043	0.00156	CcSEcCtD
Carbachol—Infection—Estradiol—prostate cancer	0.000429	0.00155	CcSEcCtD
Carbachol—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000426	0.00154	CcSEcCtD
Carbachol—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000426	0.00154	CcSEcCtD
Carbachol—Shock—Estradiol—prostate cancer	0.000424	0.00154	CcSEcCtD
Carbachol—Vomiting—Ethinyl Estradiol—prostate cancer	0.00042	0.00152	CcSEcCtD
Carbachol—Hyperhidrosis—Estradiol—prostate cancer	0.000417	0.00151	CcSEcCtD
Carbachol—Rash—Ethinyl Estradiol—prostate cancer	0.000417	0.00151	CcSEcCtD
Carbachol—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000417	0.00151	CcSEcCtD
Carbachol—Headache—Ethinyl Estradiol—prostate cancer	0.000414	0.0015	CcSEcCtD
Carbachol—Sweating increased—Prednisone—prostate cancer	0.00041	0.00149	CcSEcCtD
Carbachol—Phlebitis—Doxorubicin—prostate cancer	0.00041	0.00148	CcSEcCtD
Carbachol—Infection—Mitoxantrone—prostate cancer	0.000399	0.00145	CcSEcCtD
Carbachol—Shock—Mitoxantrone—prostate cancer	0.000395	0.00143	CcSEcCtD
Carbachol—Muscle spasms—Etoposide—prostate cancer	0.000394	0.00143	CcSEcCtD
Carbachol—Nausea—Ethinyl Estradiol—prostate cancer	0.000393	0.00142	CcSEcCtD
Carbachol—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000389	0.00141	CcSEcCtD
Carbachol—Hyponatraemia—Epirubicin—prostate cancer	0.000383	0.00139	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Epirubicin—prostate cancer	0.000381	0.00138	CcSEcCtD
Carbachol—Dyspepsia—Estradiol—prostate cancer	0.00038	0.00138	CcSEcCtD
Carbachol—Hypotension—Mitoxantrone—prostate cancer	0.000376	0.00136	CcSEcCtD
Carbachol—Diarrhoea—Goserelin—prostate cancer	0.000372	0.00135	CcSEcCtD
Carbachol—Pain—Estradiol—prostate cancer	0.000369	0.00134	CcSEcCtD
Carbachol—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000369	0.00134	CcSEcCtD
Carbachol—Flushing—Docetaxel—prostate cancer	0.000363	0.00132	CcSEcCtD
Carbachol—Loss of consciousness—Etoposide—prostate cancer	0.00036	0.00131	CcSEcCtD
Carbachol—Dizziness—Goserelin—prostate cancer	0.00036	0.0013	CcSEcCtD
Carbachol—Dizziness—Conjugated Estrogens—prostate cancer	0.000356	0.00129	CcSEcCtD
Carbachol—Hyponatraemia—Doxorubicin—prostate cancer	0.000354	0.00128	CcSEcCtD
Carbachol—Dyspepsia—Mitoxantrone—prostate cancer	0.000354	0.00128	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Doxorubicin—prostate cancer	0.000353	0.00128	CcSEcCtD
Carbachol—Flushing—Capecitabine—prostate cancer	0.000351	0.00127	CcSEcCtD
Carbachol—Arrhythmia—Docetaxel—prostate cancer	0.000349	0.00127	CcSEcCtD
Carbachol—Vomiting—Goserelin—prostate cancer	0.000346	0.00125	CcSEcCtD
Carbachol—Pain—Mitoxantrone—prostate cancer	0.000344	0.00125	CcSEcCtD
Carbachol—Rash—Goserelin—prostate cancer	0.000343	0.00124	CcSEcCtD
Carbachol—Dermatitis—Goserelin—prostate cancer	0.000343	0.00124	CcSEcCtD
Carbachol—Vomiting—Conjugated Estrogens—prostate cancer	0.000343	0.00124	CcSEcCtD
Carbachol—Abdominal pain—Estradiol—prostate cancer	0.000341	0.00124	CcSEcCtD
Carbachol—Body temperature increased—Estradiol—prostate cancer	0.000341	0.00124	CcSEcCtD
Carbachol—Headache—Goserelin—prostate cancer	0.000341	0.00124	CcSEcCtD
Carbachol—Rash—Conjugated Estrogens—prostate cancer	0.00034	0.00123	CcSEcCtD
Carbachol—Dermatitis—Conjugated Estrogens—prostate cancer	0.00034	0.00123	CcSEcCtD
Carbachol—Arrhythmia—Capecitabine—prostate cancer	0.000338	0.00123	CcSEcCtD
Carbachol—Headache—Conjugated Estrogens—prostate cancer	0.000338	0.00122	CcSEcCtD
Carbachol—Infection—Etoposide—prostate cancer	0.000332	0.0012	CcSEcCtD
Carbachol—Asthma—Epirubicin—prostate cancer	0.00033	0.00119	CcSEcCtD
Carbachol—Muscle spasms—Docetaxel—prostate cancer	0.000327	0.00119	CcSEcCtD
Carbachol—Flatulence—Capecitabine—prostate cancer	0.000325	0.00118	CcSEcCtD
Carbachol—Nausea—Goserelin—prostate cancer	0.000323	0.00117	CcSEcCtD
Carbachol—Hyperhidrosis—Etoposide—prostate cancer	0.000323	0.00117	CcSEcCtD
Carbachol—Nausea—Conjugated Estrogens—prostate cancer	0.00032	0.00116	CcSEcCtD
Carbachol—Abdominal pain—Mitoxantrone—prostate cancer	0.000318	0.00115	CcSEcCtD
Carbachol—Body temperature increased—Mitoxantrone—prostate cancer	0.000318	0.00115	CcSEcCtD
Carbachol—Muscle spasms—Capecitabine—prostate cancer	0.000317	0.00115	CcSEcCtD
Carbachol—Flushing—Prednisone—prostate cancer	0.000313	0.00113	CcSEcCtD
Carbachol—Hypotension—Etoposide—prostate cancer	0.000312	0.00113	CcSEcCtD
Carbachol—Syncope—Docetaxel—prostate cancer	0.000305	0.00111	CcSEcCtD
Carbachol—Asthma—Doxorubicin—prostate cancer	0.000305	0.00111	CcSEcCtD
Carbachol—Arrhythmia—Prednisone—prostate cancer	0.000301	0.00109	CcSEcCtD
Carbachol—Loss of consciousness—Docetaxel—prostate cancer	0.000299	0.00108	CcSEcCtD
Carbachol—Syncope—Capecitabine—prostate cancer	0.000296	0.00107	CcSEcCtD
Carbachol—Diarrhoea—Estradiol—prostate cancer	0.000295	0.00107	CcSEcCtD
Carbachol—Loss of consciousness—Capecitabine—prostate cancer	0.00029	0.00105	CcSEcCtD
Carbachol—Pain—Etoposide—prostate cancer	0.000286	0.00104	CcSEcCtD
Carbachol—Dizziness—Estradiol—prostate cancer	0.000285	0.00103	CcSEcCtD
Carbachol—Sweating—Epirubicin—prostate cancer	0.000282	0.00102	CcSEcCtD
Carbachol—Infection—Docetaxel—prostate cancer	0.000276	0.001	CcSEcCtD
Carbachol—Diarrhoea—Mitoxantrone—prostate cancer	0.000275	0.000997	CcSEcCtD
Carbachol—Vomiting—Estradiol—prostate cancer	0.000274	0.000994	CcSEcCtD
Carbachol—Shock—Docetaxel—prostate cancer	0.000273	0.000991	CcSEcCtD
Carbachol—Rash—Estradiol—prostate cancer	0.000272	0.000986	CcSEcCtD
Carbachol—Dermatitis—Estradiol—prostate cancer	0.000272	0.000985	CcSEcCtD
Carbachol—Headache—Estradiol—prostate cancer	0.00027	0.00098	CcSEcCtD
Carbachol—Infection—Capecitabine—prostate cancer	0.000267	0.000969	CcSEcCtD
Carbachol—Shock—Capecitabine—prostate cancer	0.000265	0.000959	CcSEcCtD
Carbachol—Body temperature increased—Etoposide—prostate cancer	0.000264	0.000958	CcSEcCtD
Carbachol—Abdominal pain—Etoposide—prostate cancer	0.000264	0.000958	CcSEcCtD
Carbachol—Syncope—Prednisone—prostate cancer	0.000263	0.000955	CcSEcCtD
Carbachol—Sweating—Doxorubicin—prostate cancer	0.000261	0.000945	CcSEcCtD
Carbachol—Hyperhidrosis—Capecitabine—prostate cancer	0.00026	0.000943	CcSEcCtD
Carbachol—Hypotension—Docetaxel—prostate cancer	0.00026	0.000941	CcSEcCtD
Carbachol—Loss of consciousness—Prednisone—prostate cancer	0.000258	0.000936	CcSEcCtD
Carbachol—Nausea—Estradiol—prostate cancer	0.000256	0.000929	CcSEcCtD
Carbachol—Vomiting—Mitoxantrone—prostate cancer	0.000256	0.000926	CcSEcCtD
Carbachol—Rash—Mitoxantrone—prostate cancer	0.000253	0.000919	CcSEcCtD
Carbachol—Dermatitis—Mitoxantrone—prostate cancer	0.000253	0.000918	CcSEcCtD
Carbachol—Headache—Mitoxantrone—prostate cancer	0.000252	0.000913	CcSEcCtD
Carbachol—Hypotension—Capecitabine—prostate cancer	0.000251	0.000911	CcSEcCtD
Carbachol—Flushing—Epirubicin—prostate cancer	0.000245	0.000888	CcSEcCtD
Carbachol—Dyspepsia—Docetaxel—prostate cancer	0.000245	0.000887	CcSEcCtD
Carbachol—Nausea—Mitoxantrone—prostate cancer	0.000239	0.000866	CcSEcCtD
Carbachol—Infection—Prednisone—prostate cancer	0.000238	0.000863	CcSEcCtD
Carbachol—Pain—Docetaxel—prostate cancer	0.000238	0.000861	CcSEcCtD
Carbachol—Dyspepsia—Capecitabine—prostate cancer	0.000237	0.000858	CcSEcCtD
Carbachol—Shock—Prednisone—prostate cancer	0.000236	0.000855	CcSEcCtD
Carbachol—Arrhythmia—Epirubicin—prostate cancer	0.000236	0.000854	CcSEcCtD
Carbachol—Hyperhidrosis—Prednisone—prostate cancer	0.000232	0.00084	CcSEcCtD
Carbachol—Pain—Capecitabine—prostate cancer	0.00023	0.000834	CcSEcCtD
Carbachol—Diarrhoea—Etoposide—prostate cancer	0.000229	0.000829	CcSEcCtD
Carbachol—Flushing—Doxorubicin—prostate cancer	0.000227	0.000821	CcSEcCtD
Carbachol—Flatulence—Epirubicin—prostate cancer	0.000226	0.00082	CcSEcCtD
Carbachol—Dizziness—Etoposide—prostate cancer	0.000221	0.000802	CcSEcCtD
Carbachol—Muscle spasms—Epirubicin—prostate cancer	0.000221	0.0008	CcSEcCtD
Carbachol—Abdominal pain—Docetaxel—prostate cancer	0.00022	0.000796	CcSEcCtD
Carbachol—Body temperature increased—Docetaxel—prostate cancer	0.00022	0.000796	CcSEcCtD
Carbachol—Arrhythmia—Doxorubicin—prostate cancer	0.000218	0.00079	CcSEcCtD
Carbachol—Abdominal pain—Capecitabine—prostate cancer	0.000213	0.000771	CcSEcCtD
Carbachol—Body temperature increased—Capecitabine—prostate cancer	0.000213	0.000771	CcSEcCtD
Carbachol—Vomiting—Etoposide—prostate cancer	0.000213	0.000771	CcSEcCtD
Carbachol—Dyspepsia—Prednisone—prostate cancer	0.000211	0.000765	CcSEcCtD
Carbachol—Rash—Etoposide—prostate cancer	0.000211	0.000764	CcSEcCtD
Carbachol—Dermatitis—Etoposide—prostate cancer	0.000211	0.000764	CcSEcCtD
Carbachol—Headache—Etoposide—prostate cancer	0.000209	0.000759	CcSEcCtD
Carbachol—Flatulence—Doxorubicin—prostate cancer	0.000209	0.000759	CcSEcCtD
Carbachol—Syncope—Epirubicin—prostate cancer	0.000206	0.000747	CcSEcCtD
Carbachol—Muscle spasms—Doxorubicin—prostate cancer	0.000204	0.000741	CcSEcCtD
Carbachol—Loss of consciousness—Epirubicin—prostate cancer	0.000202	0.000732	CcSEcCtD
Carbachol—Nausea—Etoposide—prostate cancer	0.000199	0.00072	CcSEcCtD
Carbachol—PLA2G4A—Dexamethasone—Prednisone—prostate cancer	0.000196	0.0256	CbGdCrCtD
Carbachol—PLA2G4A—Betamethasone—Prednisone—prostate cancer	0.000196	0.0256	CbGdCrCtD
Carbachol—Syncope—Doxorubicin—prostate cancer	0.000191	0.000691	CcSEcCtD
Carbachol—Diarrhoea—Docetaxel—prostate cancer	0.00019	0.000689	CcSEcCtD
Carbachol—Abdominal pain—Prednisone—prostate cancer	0.000189	0.000687	CcSEcCtD
Carbachol—Body temperature increased—Prednisone—prostate cancer	0.000189	0.000687	CcSEcCtD
Carbachol—Loss of consciousness—Doxorubicin—prostate cancer	0.000187	0.000677	CcSEcCtD
Carbachol—Infection—Epirubicin—prostate cancer	0.000186	0.000675	CcSEcCtD
Carbachol—Shock—Epirubicin—prostate cancer	0.000184	0.000668	CcSEcCtD
Carbachol—Diarrhoea—Capecitabine—prostate cancer	0.000184	0.000667	CcSEcCtD
Carbachol—Dizziness—Docetaxel—prostate cancer	0.000184	0.000666	CcSEcCtD
Carbachol—Hyperhidrosis—Epirubicin—prostate cancer	0.000181	0.000657	CcSEcCtD
Carbachol—Dizziness—Capecitabine—prostate cancer	0.000178	0.000645	CcSEcCtD
Carbachol—Vomiting—Docetaxel—prostate cancer	0.000177	0.00064	CcSEcCtD
Carbachol—Rash—Docetaxel—prostate cancer	0.000175	0.000635	CcSEcCtD
Carbachol—Hypotension—Epirubicin—prostate cancer	0.000175	0.000635	CcSEcCtD
Carbachol—Dermatitis—Docetaxel—prostate cancer	0.000175	0.000635	CcSEcCtD
Carbachol—Headache—Docetaxel—prostate cancer	0.000174	0.000631	CcSEcCtD
Carbachol—Infection—Doxorubicin—prostate cancer	0.000172	0.000625	CcSEcCtD
Carbachol—Vomiting—Capecitabine—prostate cancer	0.000171	0.00062	CcSEcCtD
Carbachol—Shock—Doxorubicin—prostate cancer	0.000171	0.000618	CcSEcCtD
Carbachol—Rash—Capecitabine—prostate cancer	0.00017	0.000615	CcSEcCtD
Carbachol—Dermatitis—Capecitabine—prostate cancer	0.000169	0.000614	CcSEcCtD
Carbachol—Headache—Capecitabine—prostate cancer	0.000169	0.000611	CcSEcCtD
Carbachol—Hyperhidrosis—Doxorubicin—prostate cancer	0.000168	0.000608	CcSEcCtD
Carbachol—Nausea—Docetaxel—prostate cancer	0.000165	0.000598	CcSEcCtD
Carbachol—Dyspepsia—Epirubicin—prostate cancer	0.000165	0.000598	CcSEcCtD
Carbachol—Diarrhoea—Prednisone—prostate cancer	0.000164	0.000594	CcSEcCtD
Carbachol—Hypotension—Doxorubicin—prostate cancer	0.000162	0.000587	CcSEcCtD
Carbachol—Pain—Epirubicin—prostate cancer	0.00016	0.000581	CcSEcCtD
Carbachol—Nausea—Capecitabine—prostate cancer	0.00016	0.000579	CcSEcCtD
Carbachol—Dizziness—Prednisone—prostate cancer	0.000158	0.000574	CcSEcCtD
Carbachol—Dyspepsia—Doxorubicin—prostate cancer	0.000153	0.000553	CcSEcCtD
Carbachol—Vomiting—Prednisone—prostate cancer	0.000152	0.000552	CcSEcCtD
Carbachol—Rash—Prednisone—prostate cancer	0.000151	0.000548	CcSEcCtD
Carbachol—Dermatitis—Prednisone—prostate cancer	0.000151	0.000547	CcSEcCtD
Carbachol—Headache—Prednisone—prostate cancer	0.00015	0.000544	CcSEcCtD
Carbachol—Pain—Doxorubicin—prostate cancer	0.000148	0.000538	CcSEcCtD
Carbachol—Abdominal pain—Epirubicin—prostate cancer	0.000148	0.000537	CcSEcCtD
Carbachol—Body temperature increased—Epirubicin—prostate cancer	0.000148	0.000537	CcSEcCtD
Carbachol—Nausea—Prednisone—prostate cancer	0.000142	0.000516	CcSEcCtD
Carbachol—Abdominal pain—Doxorubicin—prostate cancer	0.000137	0.000497	CcSEcCtD
Carbachol—Body temperature increased—Doxorubicin—prostate cancer	0.000137	0.000497	CcSEcCtD
Carbachol—Diarrhoea—Epirubicin—prostate cancer	0.000128	0.000465	CcSEcCtD
Carbachol—Dizziness—Epirubicin—prostate cancer	0.000124	0.000449	CcSEcCtD
Carbachol—Vomiting—Epirubicin—prostate cancer	0.000119	0.000432	CcSEcCtD
Carbachol—Diarrhoea—Doxorubicin—prostate cancer	0.000119	0.00043	CcSEcCtD
Carbachol—Rash—Epirubicin—prostate cancer	0.000118	0.000428	CcSEcCtD
Carbachol—Dermatitis—Epirubicin—prostate cancer	0.000118	0.000428	CcSEcCtD
Carbachol—Headache—Epirubicin—prostate cancer	0.000117	0.000426	CcSEcCtD
Carbachol—Dizziness—Doxorubicin—prostate cancer	0.000115	0.000416	CcSEcCtD
Carbachol—Nausea—Epirubicin—prostate cancer	0.000111	0.000404	CcSEcCtD
Carbachol—Vomiting—Doxorubicin—prostate cancer	0.00011	0.0004	CcSEcCtD
Carbachol—Rash—Doxorubicin—prostate cancer	0.000109	0.000396	CcSEcCtD
Carbachol—Dermatitis—Doxorubicin—prostate cancer	0.000109	0.000396	CcSEcCtD
Carbachol—Headache—Doxorubicin—prostate cancer	0.000109	0.000394	CcSEcCtD
Carbachol—Nausea—Doxorubicin—prostate cancer	0.000103	0.000373	CcSEcCtD
Carbachol—CHRM3—Signaling Pathways—TGFBR2—prostate cancer	1.51e-05	9.83e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—SERPINE1—prostate cancer	1.49e-05	9.73e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TGFBR2—prostate cancer	1.49e-05	9.73e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ITPR1—prostate cancer	1.49e-05	9.7e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ITPR1—prostate cancer	1.48e-05	9.67e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—KRAS—prostate cancer	1.48e-05	9.63e-05	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—PIK3CB—prostate cancer	1.47e-05	9.61e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—PIK3CB—prostate cancer	1.47e-05	9.58e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ITPR1—prostate cancer	1.47e-05	9.57e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—MTHFR—prostate cancer	1.46e-05	9.54e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—PIK3CB—prostate cancer	1.46e-05	9.48e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—FGF2—prostate cancer	1.45e-05	9.42e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PPARA—prostate cancer	1.44e-05	9.36e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—NOS3—prostate cancer	1.43e-05	9.29e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IGF1R—prostate cancer	1.42e-05	9.27e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IGF1R—prostate cancer	1.42e-05	9.24e-05	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—CXCL8—prostate cancer	1.42e-05	9.23e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—CXCL8—prostate cancer	1.41e-05	9.2e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—JAK2—prostate cancer	1.41e-05	9.19e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—JAK2—prostate cancer	1.41e-05	9.16e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IGF1R—prostate cancer	1.41e-05	9.15e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—CXCL8—prostate cancer	1.4e-05	9.11e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—JAK2—prostate cancer	1.39e-05	9.07e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—JAK2—prostate cancer	1.39e-05	9.03e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—LPL—prostate cancer	1.36e-05	8.89e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—LPL—prostate cancer	1.36e-05	8.86e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PTEN—prostate cancer	1.36e-05	8.86e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—PIK3CA—prostate cancer	1.36e-05	8.85e-05	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—IL2—prostate cancer	1.35e-05	8.82e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MDM2—prostate cancer	1.35e-05	8.81e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PDGFRB—prostate cancer	1.35e-05	8.81e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—CAV1—prostate cancer	1.35e-05	8.8e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—IL2—prostate cancer	1.35e-05	8.8e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PDGFRB—prostate cancer	1.35e-05	8.78e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—LPL—prostate cancer	1.35e-05	8.78e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PIK3CB—prostate cancer	1.34e-05	8.72e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—IL2—prostate cancer	1.34e-05	8.71e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PDGFRB—prostate cancer	1.34e-05	8.7e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PIK3CB—prostate cancer	1.33e-05	8.7e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—ERBB2—prostate cancer	1.33e-05	8.69e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PIK3CB—prostate cancer	1.32e-05	8.61e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ITGB3—prostate cancer	1.32e-05	8.59e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PIK3CB—prostate cancer	1.32e-05	8.58e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ITGB3—prostate cancer	1.31e-05	8.56e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ITGB3—prostate cancer	1.3e-05	8.48e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—EP300—prostate cancer	1.3e-05	8.45e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CXCL8—prostate cancer	1.29e-05	8.38e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CXCL8—prostate cancer	1.28e-05	8.36e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ERBB3—prostate cancer	1.28e-05	8.33e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—FGFR2—prostate cancer	1.28e-05	8.32e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ERBB3—prostate cancer	1.27e-05	8.3e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—FGFR2—prostate cancer	1.27e-05	8.29e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CXCL8—prostate cancer	1.27e-05	8.28e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CXCL8—prostate cancer	1.26e-05	8.24e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ERBB3—prostate cancer	1.26e-05	8.22e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—FGFR2—prostate cancer	1.26e-05	8.21e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CDKN1B—prostate cancer	1.24e-05	8.05e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3CG—prostate cancer	1.23e-05	8.02e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—IL2—prostate cancer	1.23e-05	8.01e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—IL2—prostate cancer	1.23e-05	7.99e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TERT—prostate cancer	1.23e-05	7.98e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TERT—prostate cancer	1.22e-05	7.96e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—IL2—prostate cancer	1.21e-05	7.91e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CASP3—prostate cancer	1.21e-05	7.89e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TERT—prostate cancer	1.21e-05	7.88e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IL2—prostate cancer	1.21e-05	7.88e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—IL6—prostate cancer	1.2e-05	7.84e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CCND1—prostate cancer	1.18e-05	7.68e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HIF1A—prostate cancer	1.17e-05	7.63e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HIF1A—prostate cancer	1.17e-05	7.61e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CTNNB1—prostate cancer	1.17e-05	7.6e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—INS—prostate cancer	1.17e-05	7.59e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HIF1A—prostate cancer	1.16e-05	7.54e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MMP9—prostate cancer	1.14e-05	7.45e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—LEP—prostate cancer	1.14e-05	7.45e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—CREBBP—prostate cancer	1.14e-05	7.43e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—LEP—prostate cancer	1.14e-05	7.43e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CDKN1A—prostate cancer	1.14e-05	7.43e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PTEN—prostate cancer	1.14e-05	7.41e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CAV1—prostate cancer	1.13e-05	7.38e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CAV1—prostate cancer	1.13e-05	7.36e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—LEP—prostate cancer	1.13e-05	7.36e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—KDR—prostate cancer	1.12e-05	7.3e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CAV1—prostate cancer	1.12e-05	7.29e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—KDR—prostate cancer	1.12e-05	7.28e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—AKT1—prostate cancer	1.11e-05	7.23e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—KDR—prostate cancer	1.11e-05	7.21e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ESR1—prostate cancer	1.09e-05	7.12e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ESR1—prostate cancer	1.09e-05	7.09e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—EP300—prostate cancer	1.08e-05	7.07e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3CD—prostate cancer	1.08e-05	7.05e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ESR1—prostate cancer	1.08e-05	7.02e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—BAD—prostate cancer	1.07e-05	6.94e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—BAD—prostate cancer	1.06e-05	6.92e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—SRC—prostate cancer	1.05e-05	6.87e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—BAD—prostate cancer	1.05e-05	6.86e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—APC—prostate cancer	1.03e-05	6.73e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3CG—prostate cancer	1.03e-05	6.73e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—APC—prostate cancer	1.03e-05	6.7e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3CG—prostate cancer	1.03e-05	6.7e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—VEGFA—prostate cancer	1.03e-05	6.69e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—NOS3—prostate cancer	1.02e-05	6.66e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IRS1—prostate cancer	1.02e-05	6.65e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—EGF—prostate cancer	1.02e-05	6.65e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3CG—prostate cancer	1.02e-05	6.64e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—APC—prostate cancer	1.02e-05	6.64e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—STAT3—prostate cancer	1.02e-05	6.63e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—EGF—prostate cancer	1.02e-05	6.63e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IRS1—prostate cancer	1.02e-05	6.63e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—EGF—prostate cancer	1.01e-05	6.56e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IRS1—prostate cancer	1.01e-05	6.56e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—GSK3B—prostate cancer	9.91e-06	6.45e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—GSK3B—prostate cancer	9.88e-06	6.43e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—GSK3B—prostate cancer	9.78e-06	6.37e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—INS—prostate cancer	9.77e-06	6.37e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—INS—prostate cancer	9.74e-06	6.35e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—INS—prostate cancer	9.65e-06	6.29e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PIK3CA—prostate cancer	9.6e-06	6.25e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CREBBP—prostate cancer	9.57e-06	6.24e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CREBBP—prostate cancer	9.54e-06	6.22e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IGF1—prostate cancer	9.45e-06	6.16e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MYC—prostate cancer	9.45e-06	6.16e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CREBBP—prostate cancer	9.45e-06	6.16e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3CB—prostate cancer	9.43e-06	6.14e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TGFB1—prostate cancer	9.43e-06	6.14e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IGF1—prostate cancer	9.42e-06	6.14e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—EGFR—prostate cancer	9.41e-06	6.13e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—EGFR—prostate cancer	9.38e-06	6.11e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PTGS2—prostate cancer	9.34e-06	6.09e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IGF1—prostate cancer	9.33e-06	6.08e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—EGFR—prostate cancer	9.29e-06	6.05e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—EGFR—prostate cancer	9.25e-06	6.02e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MAP2K1—prostate cancer	9.14e-06	5.95e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MAP2K1—prostate cancer	9.11e-06	5.93e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3CD—prostate cancer	9.08e-06	5.91e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3CD—prostate cancer	9.05e-06	5.89e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MAP2K1—prostate cancer	9.02e-06	5.88e-05	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—PIK3CA—prostate cancer	8.99e-06	5.86e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SERPINE1—prostate cancer	8.98e-06	5.85e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—PIK3CA—prostate cancer	8.96e-06	5.84e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3CD—prostate cancer	8.96e-06	5.84e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SERPINE1—prostate cancer	8.95e-06	5.83e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—KRAS—prostate cancer	8.89e-06	5.79e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—PIK3CA—prostate cancer	8.87e-06	5.78e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SERPINE1—prostate cancer	8.86e-06	5.77e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—KRAS—prostate cancer	8.86e-06	5.77e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—KRAS—prostate cancer	8.77e-06	5.71e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—KRAS—prostate cancer	8.73e-06	5.69e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—FGF2—prostate cancer	8.69e-06	5.66e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—FGF2—prostate cancer	8.66e-06	5.64e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—FGF2—prostate cancer	8.58e-06	5.59e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NOS3—prostate cancer	8.57e-06	5.58e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NOS3—prostate cancer	8.54e-06	5.57e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NOS3—prostate cancer	8.46e-06	5.51e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—JAK2—prostate cancer	8.33e-06	5.43e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—JAK2—prostate cancer	8.3e-06	5.41e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—JAK2—prostate cancer	8.22e-06	5.36e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PIK3CA—prostate cancer	8.16e-06	5.32e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PTEN—prostate cancer	8.15e-06	5.31e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PIK3CA—prostate cancer	8.14e-06	5.3e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MDM2—prostate cancer	8.13e-06	5.3e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MDM2—prostate cancer	8.11e-06	5.28e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PIK3CA—prostate cancer	8.06e-06	5.25e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MDM2—prostate cancer	8.03e-06	5.23e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PIK3CA—prostate cancer	8.02e-06	5.23e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ERBB2—prostate cancer	8.02e-06	5.22e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ERBB2—prostate cancer	7.99e-06	5.21e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ERBB2—prostate cancer	7.91e-06	5.16e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3CB—prostate cancer	7.91e-06	5.15e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3CB—prostate cancer	7.89e-06	5.14e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—AKT1—prostate cancer	7.84e-06	5.11e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3CB—prostate cancer	7.81e-06	5.09e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—EP300—prostate cancer	7.77e-06	5.06e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TP53—prostate cancer	7.76e-06	5.06e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CXCL8—prostate cancer	7.6e-06	4.95e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CXCL8—prostate cancer	7.58e-06	4.94e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CXCL8—prostate cancer	7.5e-06	4.89e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CDKN1B—prostate cancer	7.42e-06	4.84e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CDKN1B—prostate cancer	7.4e-06	4.82e-05	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—AKT1—prostate cancer	7.34e-06	4.78e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CDKN1B—prostate cancer	7.33e-06	4.77e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—AKT1—prostate cancer	7.32e-06	4.77e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CASP3—prostate cancer	7.28e-06	4.74e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL2—prostate cancer	7.27e-06	4.73e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CASP3—prostate cancer	7.25e-06	4.73e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—AKT1—prostate cancer	7.25e-06	4.72e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL2—prostate cancer	7.24e-06	4.72e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—IL6—prostate cancer	7.23e-06	4.71e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—IL6—prostate cancer	7.21e-06	4.69e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CASP3—prostate cancer	7.18e-06	4.68e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IL2—prostate cancer	7.17e-06	4.67e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—IL6—prostate cancer	7.14e-06	4.65e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IL6—prostate cancer	7.11e-06	4.63e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CCND1—prostate cancer	7.08e-06	4.61e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CCND1—prostate cancer	7.06e-06	4.6e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CTNNB1—prostate cancer	7.01e-06	4.57e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CCND1—prostate cancer	6.99e-06	4.55e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CTNNB1—prostate cancer	6.99e-06	4.55e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	6.92e-06	4.51e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MMP9—prostate cancer	6.88e-06	4.48e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MMP9—prostate cancer	6.85e-06	4.47e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CDKN1A—prostate cancer	6.85e-06	4.46e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PTEN—prostate cancer	6.84e-06	4.45e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CDKN1A—prostate cancer	6.83e-06	4.45e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PTEN—prostate cancer	6.81e-06	4.44e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MMP9—prostate cancer	6.79e-06	4.42e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	6.76e-06	4.41e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PTEN—prostate cancer	6.75e-06	4.4e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—AKT1—prostate cancer	6.67e-06	4.34e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—AKT1—prostate cancer	6.65e-06	4.33e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—AKT1—prostate cancer	6.58e-06	4.29e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—AKT1—prostate cancer	6.56e-06	4.27e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—EP300—prostate cancer	6.52e-06	4.25e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—EP300—prostate cancer	6.5e-06	4.23e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—EP300—prostate cancer	6.44e-06	4.19e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SRC—prostate cancer	6.34e-06	4.13e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SRC—prostate cancer	6.32e-06	4.12e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SRC—prostate cancer	6.26e-06	4.08e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—VEGFA—prostate cancer	6.17e-06	4.02e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—VEGFA—prostate cancer	6.15e-06	4.01e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—STAT3—prostate cancer	6.11e-06	3.98e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—VEGFA—prostate cancer	6.1e-06	3.97e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—STAT3—prostate cancer	6.09e-06	3.97e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—STAT3—prostate cancer	6.04e-06	3.93e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3CA—prostate cancer	5.75e-06	3.75e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MYC—prostate cancer	5.68e-06	3.7e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TGFB1—prostate cancer	5.67e-06	3.69e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MYC—prostate cancer	5.66e-06	3.69e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TGFB1—prostate cancer	5.65e-06	3.68e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MYC—prostate cancer	5.61e-06	3.65e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TGFB1—prostate cancer	5.59e-06	3.64e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—EGFR—prostate cancer	5.56e-06	3.62e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—EGFR—prostate cancer	5.54e-06	3.61e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—EGFR—prostate cancer	5.49e-06	3.57e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—KRAS—prostate cancer	5.25e-06	3.42e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—KRAS—prostate cancer	5.23e-06	3.41e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—KRAS—prostate cancer	5.18e-06	3.38e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3CA—prostate cancer	4.82e-06	3.14e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3CA—prostate cancer	4.81e-06	3.13e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	4.76e-06	3.1e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—AKT1—prostate cancer	4.7e-06	3.06e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TP53—prostate cancer	4.67e-06	3.04e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TP53—prostate cancer	4.65e-06	3.03e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TP53—prostate cancer	4.61e-06	3e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL6—prostate cancer	4.27e-06	2.78e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL6—prostate cancer	4.26e-06	2.77e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IL6—prostate cancer	4.22e-06	2.75e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AKT1—prostate cancer	3.94e-06	2.57e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AKT1—prostate cancer	3.93e-06	2.56e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AKT1—prostate cancer	3.89e-06	2.53e-05	CbGpPWpGaD
